QC
AXSM icon

Quent Capital’s Axsome Therapeutics AXSM Stock Holding History

Quent Capital’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,213
Closed -$96.5K – 1361
2023
Q4 		$96.5K Hold
1,213
– – 0.01% 458
2023
Q3 		$84.8K Hold
1,213
– – 0.01% 451
2023
Q2 		$87.2K Hold
1,213
– – 0.01% 454
2023
Q1 		$74.8K Hold
1,213
– – 0.01% 483
2022
Q4 		$93.6K Hold
1,213
– – 0.02% 411
2022
Q3 		$54K Buy
+1,213
New +$60.6K 0.01% 522

Other funds holding AXSM

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Quent Capital's AXSM Position: Q1 2024 in Review

Quent Capital sold out of Axsome Therapeutics (AXSM) in Q1 2024, closing a stake of 1,213 shares — an estimated $96.5K sold.

Quent Capital first reported a position in AXSM in Q3 2022 and held it in 6 quarters. The position peaked at $96.5K in Q4 2023. 259 funds tracked by Wall St. Rank hold AXSM as of Q1 2024.

  • Quent Capital reported no remaining Axsome Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Quent Capital sold 1,213 Axsome Therapeutics shares in Q1 2024, an estimated $96.5K.
  • Quent Capital first reported a position in Axsome Therapeutics in Q3 2022 and held it in 6 quarters.
  • Quent Capital's Axsome Therapeutics position peaked at $96.5K in Q4 2023.
  • 259 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2024.

Based on Quent Capital's 13F filing for Q1 2024, filed 2 May 2024.